Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Efficient electroporation of peptides into adherent cells: investigation of the role of mechano-growth factor in chondrocyte culture

Schönenberger C, Schütz A, Franco-Obregón A, Zenobi-Wong M

Biotechnology letters1 May 2011

PepBankPUB-95194838
Ask about this study

Summary

The text of this summary is not shown here, because the article license does not allow reuse.

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking MGF / PEG-MGF.

  1. 01LabNot a test of MGF / PEG-MGF aloneIn vitro (cells)Other

    In adherent primary chondrocytes, electroporation of FITC-labeled MGF reached an efficiency of close to 50% under optimal conditions.

    In plain wordsIn cells, an electric pulse method got labeled MGF into close to 50% of cartilage cells under the best conditions.

    Outcome
    Not applicableElectroporation efficiency of FITC-labeled MGF into chondrocytes
    Study

    n: not reported in source

    Primary chondrocytes on ITO coated glass slides
    Outcome group
    Receptor activity and mechanism · Musculoskeletal

    Measurements

    Electroporation efficiency
    ≈ 50%
    optimal conditions

    Source sentences

    Summary
    Under optimal conditions, an electroporation efficiency of close to 50% could be achieved.
    1 context sentence
    Summary · context
    FITC-labeled MGF was added to cultures of adherent primary chondrocytes grown on ITO coated glass slides.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.